Nishimura, J.- ichi, Ando, K., Masuko, M., Noji, H., Ito, Y., Mayer, J., Griskevicius, L., Bucher, C., Müllershausen, F., Gergely, P., Rozenberg, I., Schubart, A., Chawla, R., Rondeau, J.-M., Roguska, M., Splawski, I., Keating, M. T., Johnson, L., Danekula, R., Bagger, M., Watanabe, Y., Haraldsson, B. and Kanakura, Y. (2022) “Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria”, Haematologica. Pavia, Italy, 107(6), pp. 1483-1488. doi: 10.3324/haematol.2020.265868.